Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Stacy Krisher"'
Autor:
Alissa M. Michel, Haeseung Yi, Jacquelyn Amenta, Nicole Collins, Anna Vaynrub, Subiksha Umakanth, Garnet Anderson, Katie Arnold, Cynthia Law, Sandhya Pruthi, Ana Sandoval-Leon, Rachel Shirley, Maria Grosse Perdekamp, Sarah Colonna, Stacy Krisher, Tari King, Lisa D. Yee, Tarah J. Ballinger, Christa Braun-Inglis, Debra A. Mangino, Kari Wisinski, Claudia A. DeYoung, Masey Ross, Justin Floyd, Andrea Kaster, Lindi VanderWalde, Thomas J. Saphner, Corrine Zarwan, Shelly Lo, Cathy Graham, Alison Conlin, Kathleen Yost, Doreen Agnese, Cheryl Jernigan, Dawn L. Hershman, Marian L. Neuhouser, Banu Arun, Katherine D. Crew, Rita Kukafka
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Women with high-risk breast lesions, such as atypical hyperplasia (AH) or lobular carcinoma in situ (LCIS), have a 4- to tenfold increased risk of breast cancer compared to women with non-proliferative breast disease. Despite high
Externí odkaz:
https://doaj.org/article/7ac042041f3a4b14993e75986bbff3f6
Autor:
Katherine D. Crew, Garnet Anderson, Kathryn Arnold, Andrew Stieb, Jacquelyn N. Amenta, Cynthia Law, Ana Sandoval-Leon, Sarah Colonna, Tari King, Debra Mangino, Sandhya Pruthi, Maria Grosse Perdekamp, Christa Braun-Inglis, Stacy Krisher, Lisa Yee, Danielle Bertoni, Samantha Seaward, Kari B. Wisinski, Justin Floyd, Corrine Zarwan, Tarah J. Ballinger, Lindi VanderWalde, Masey M. Ross, Preston Steen, Shelly Lo, Alison Conlin, Kathleen Yost, John Ellerton, Erin Lin, Holly J. Pederson, Sagar Sardesai, Cheryl Jernigan, Dawn Hershman, Marian L. Neuhouser, Banu K. Arun, Rita Kukafka
Publikováno v:
Cancer Research. 83:OT1-15
Background: Despite evidence of substantial breast cancer risk reduction, few high-risk women adopt chemopreventive medications such as selective estrogen receptor modulators (SERMs) or aromatase inhibitors (AIs). Women with benign breast disease, su